It would seem that the time when machines surpass the ability of humans to do intricate work is almost here. One of Google’s Artificial Intelligence projects is apparently capable of diagnosing the retina of patients to see if they are about to go blind. The search engine company even went so far as to claim that the AI is better than actual doctors at diagnosis.
As Google noted in a blog post about the AI, Diabetic retinopathy is a quickly rising cause of blindness among patients in the world. The disease is treatable, but only if it is caught early enough to respond to treatments. This is where effective diagnosis comes into play.
“Unfortunately, medical specialists capable of detecting the disease are not available in many parts of the world where diabetes is prevalent,” the blog post reads. “We believe that Machine Learning can help doctors identify patients in need, particularly among underserved populations.”
The findings with regards to the diagnostic capabilities of the AI was published in the Journal of the American Medical Association. The paper included proposals on certain potential benefits that machine learning could provide with regards to diagnosing medical problems and even helping to find ways to treat them.
In the case of blindness caused by Diabetic retinopathy, the AI is fed images of retinas, which it will then scan and analyze for any of the telltale sign of impending blindness. After going through 128,000 images of retinas with the traits that led to the condition, the AI was given 10,000 new images to diagnose. Based on the results, the machine was much better at detecting which images posed the biggest threat of blindness for the subjects.
There are significant advantages to having this kind of powerful tool, especially with regards to detecting and curing diseases. However, there is also the startling implication that if a machine can replace vocations as complex and important as those in the medical profession, just how much of human society can AI replace?


Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
OpenAI's $34B Spending Pushes AI Market Leadership Ahead of IPO
Anthropic Officials Meet White House Over AI Model Outage
Anthropic Restricts Global Access to AI Models After U.S. Security Review
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
Hanmi Semicon Shares Surge After $33 Million SpaceX Investment
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation
AI Memory Boom Sparks Global Chip Supply Crunch
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
SpaceX Surpasses Amazon in Market Value as Post-IPO Rally Accelerates
SoftBank Vision Fund CFO Navneet Govil to Exit After Decade-Long Tenure
US Raises Concerns Over Possible ASML EUV Machine Transfer to China
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



